Thomas Hofer
28Patents
11h-index
45Co-inventors
71Inventor score
Filing activity: Sep 30, 2009 → May 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9447159B2 | Immunoconjugates | Chemistry; Metallurgy | 94 | Active |
| US9266938B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 88 | Active |
| US10184009B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 33 | Active |
| US9068008B2 | Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof | Chemistry; Metallurgy | 29 | Active |
| US10202464B2 | Immunoconjugates | Chemistry; Metallurgy | 28 | Active |
| US10316104B2 | Immunoconjugates | Chemistry; Metallurgy | 27 | Active |
| US10323098B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 23 | Active |
| US8642742B2 | Anti-CEA antibodies | Chemistry; Metallurgy | 20 | Active |
| US9206260B2 | Anti-CEA antibodies | Chemistry; Metallurgy | 17 | Active |
| US11130822B2 | Immunoconjugates | Chemistry; Metallurgy | 13 | Active |
| US9771427B2 | ASGPR antibodies and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10155815B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 8 | Active |
| US11111312B2 | Mutant interleukin-2 polypeptides | Chemistry; Metallurgy | 6 | Active |
| US8916159B2 | Selenocysteine mediated hybrid antibody molecules | Human Necessities | 3 | Active |
| US11608376B2 | Tumor-targeted agonistic CD28 antigen binding molecules | Chemistry; Metallurgy | 2 | Active |
| US10781258B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 1 | Active |
| US10584178B2 | Bispecific HER2 antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US10781257B2 | Bispecific T cell activating antigen binding molecules | Chemistry; Metallurgy | 1 | Active |
| US10087254B2 | ASPGR antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12129306B2 | Antibodies binding to STEAP-1 | Chemistry; Metallurgy | 0 | Active |
| US12049515B2 | Agonistic CD28 antigen binding molecules targeting Her2 | Chemistry; Metallurgy | 0 | Active |
| US12258371B2 | Stabilized immunoglobulin domains | Chemistry; Metallurgy | 0 | Active |
| US11672858B2 | Bispecific antibody molecules binding to CD3 and TYRP-1 | Chemistry; Metallurgy | 0 | Active |
| US11180571B2 | Antibodies binding to STEAP-1 | Chemistry; Metallurgy | 0 | Active |
| US11591397B2 | Bispecific antibody molecules binding to CD3 and EGFRvIII | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.